Home › Funds › SECTOR GAMMA AS › DNLI

SECTOR GAMMA AS position in DNLI

DENALI THERAPEUTICS INC · Health Care

SECTOR GAMMA AS reported holding 137,718 shares of DNLI (DENALI THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.8M, representing 0.59% of its reported portfolio and ranking #39 among its reported holdings. SECTOR GAMMA AS has disclosed DNLI holdings in 2 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)137.72K sh
Reported value held$2.85M
Portfolio Weight0.59%
First reportedQ1 2026
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SECTOR GAMMA AS's DNLI position evolved

SECTOR GAMMA AS first disclosed a stake in DNLI in Q1 2026 at 162,710 shares (US$3.1M). Across 2 filings, SECTOR GAMMA AS held the position steady without any share-count change. The most recent filing (Q3 2026) shows 137,718 shares valued at US$2.8M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 162.71K $3.12M New
Q3 2026 137.72K $2.85M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DNLI and 13F data

DNLI (DENALI THERAPEUTICS INC) is a Health Care company. 40 other funds we track also report a position in DNLI — the largest reported positions include Temasek Holdings (US$180.4M), Temasek Holdings (Private) Ltd (US$145.0M), BAKER BROS. ADVISORS LP (US$96.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DNLI

All DNLI fund holders →

FAQ

How long has SECTOR GAMMA AS held DNLI?

SECTOR GAMMA AS has disclosed DNLI holdings in 2 of the last 3 reported quarters, going back to Q1 2026.

What is SECTOR GAMMA AS's current position in DNLI?

As of Q3 2026, SECTOR GAMMA AS holds 137.72K shares of DNLI (DENALI THERAPEUTICS INC), valued at $2.85M, representing 0.59% of its reported portfolio and ranking #39.

Has SECTOR GAMMA AS been buying or selling DNLI?

In the latest 13F filing (Q3 2026), SECTOR GAMMA AS newly opened its position in DNLI.

Which other funds hold DNLI?

Other major institutional holders of DNLI include Temasek Holdings, Temasek Holdings (Private) Ltd, BAKER BROS. ADVISORS LP, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.